New Positive Data From Largest Real-World Study of Deep TMS in Patients With Comorbid PTSD and MDDByLeah KuntzJune 29th 2026
FDA Grants De Novo Approval to Modius Spero, Neuromodulation Device for PTSDByLeah KuntzMay 26th 2026
Childbirth-Related PTSD: Recognizing and Assessing This Unique SubtypeByAmanda Koire, MD, PhDMay 18th 2026
FDA Fast-Tracks Psychedelic Therapies for Depression, PTSD, and Alcohol Use DisorderByHeidi Anne Duerr, MPHApril 24th 2026